Standout Papers

TRPV1 alleviates osteoart... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway
    2021 176 citations Zhongyang Lv, Xingquan Xu et al. Cell Death and Disease

Immediate Impact

54 hit
Sub-graph 1 of 23

Citing Papers

Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases
2025 Hit
Thirty years of NRF2: advances and therapeutic challenges
2025 Hit
4 intermediate papers

Works of Hu Guo being referenced

Near Infrared Responsive Gold Nanorods Attenuate Osteoarthritis Progression by Targeting TRPV1
2024
TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway
2021 Hit
and 1 more

Author Peers

Author Last Decade Papers Cites
Hu Guo 233 205 103 97 95 33 613
Chenkai Li 218 157 48 89 32 23 534
Hongkun Wang 254 49 77 94 181 41 643
Zheng Li 313 94 79 117 41 24 676
Minako Murata 187 280 52 70 56 36 687
Chen Zhao 358 53 79 117 112 33 616
Zuolong Wu 257 58 78 133 44 24 557
Jianwei Lv 209 145 36 79 84 30 516
Wenfeng Xiao 221 343 29 91 69 24 618
S.J. Capper 181 79 55 38 35 19 569
R. Nieminen 100 113 96 18 45 24 531

All Works

Loading papers...

Rankless by CCL
2026